title: Hodgkin's disease in children: adaptation of treatment to risk factors.
authors: Service de Pédiatrie, Institut Gustave Roussy, Villejuif, France.
authors: J
authors: J
authors: Lemerle
authors: O
authors: O
authors: Oberlin
authors: G
authors: G
authors: Schaison
authors: G
authors: G
authors: Leverger
authors: D
authors: D
authors: Olive
authors: M
authors: M
authors: Bonnet
authors: D
authors: D
authors: Dufillot
authors: L
authors: L
authors: de Lumley
mesh_terms: D000293:Adolescent; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D001761:Bleomycin / Q000008:administration & dosage; D002648:Child; D002675:Child, Preschool; D002986:Clinical Trials as Topic; D003131:Combined Modality Therapy / Q000009:adverse effects; D003606:Dacarbazine / Q000008:administration & dosage; D004317:Doxorubicin / Q000008:administration & dosage; D005260:Female; D006689:Hodgkin Disease / Q000532:radiotherapy / Q000628:therapy*; D006801:Humans; D008297:Male; D008466:Mechlorethamine / Q000008:administration & dosage; D011241:Prednisone / Q000008:administration & dosage; D011344:Procarbazine / Q000008:administration & dosage; D011379:Prognosis; D012307:Risk Factors; D014747:Vinblastine; D014750:Vincristine / Q000008:administration & dosage
chemical_list: D001761:Bleomycin; D011344:Procarbazine; D008466:Mechlorethamine; D014750:Vincristine; D014747:Vinblastine; D003606:Dacarbazine; D004317:Doxorubicin; D011241:Prednisone